glp-1/gcgr dual agonist GLP-1-based therapies for type 2 diabetes: from single, and triple agonists to endogenous GLP-1 production and L-cell differentiation | Diabetology & Metabolic Syndrome Strategic Design of Triple GLP-1R/GCGR/GIPR
Pay in 4 interest-free payments of $5.34 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6




























